| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.83B | 35.59B | 34.54B | 35.10B | 31.88B | 32.70B |
| Gross Profit | 6.83B | 6.46B | 6.13B | 5.51B | 4.74B | 5.18B |
| EBITDA | 2.15B | 1.99B | 1.76B | 1.38B | 979.00M | 1.55B |
| Net Income | 1.70B | 1.53B | 1.37B | 1.04B | 749.00M | 698.00M |
Balance Sheet | ||||||
| Total Assets | 43.14B | 43.97B | 43.34B | 43.73B | 43.30B | 44.06B |
| Cash, Cash Equivalents and Short-Term Investments | 5.24B | 5.09B | 4.86B | 3.40B | 4.42B | 3.60B |
| Total Debt | 1.38B | 534.00M | 535.00M | 1.59B | 2.90B | 3.90B |
| Total Liabilities | 12.09B | 13.04B | 13.53B | 15.51B | 15.85B | 15.94B |
| Stockholders Equity | 31.05B | 30.93B | 29.81B | 28.22B | 27.45B | 28.12B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 397.00M | 2.72B | 497.00M | 1.34B | 2.03B |
| Operating Cash Flow | 0.00 | 1.45B | 3.20B | 756.00M | 1.57B | 2.19B |
| Investing Cash Flow | 0.00 | -805.00M | -297.00M | -161.00M | 547.00M | 177.00M |
| Financing Cash Flow | 0.00 | -404.00M | -1.38B | -1.61B | -1.31B | -930.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥20.08B | 5.36 | ― | 2.73% | 8.19% | 22.55% | |
74 Outperform | ¥343.57B | 12.83 | ― | 3.26% | -7.77% | 58.84% | |
72 Outperform | ¥56.86B | 7.14 | ― | 6.31% | -8.44% | 9.50% | |
70 Outperform | ¥102.48B | 10.61 | ― | 3.70% | -3.06% | 1.15% | |
68 Neutral | ¥12.67B | 348.54 | ― | 3.84% | -12.14% | 4.67% | |
64 Neutral | ¥33.35B | -185.54 | ― | 5.02% | -13.64% | -45.74% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |